{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:38:08Z","timestamp":1757705888922,"version":"3.41.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1006732424102","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T22:23:32Z","timestamp":1040509412000},"page":"139-146","source":"Crossref","is-referenced-by-count":22,"title":["Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells"],"prefix":"10.1007","volume":"18","author":[{"given":"Qinghui","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak D.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot M.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saijun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"278826_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(84)80023-3","volume":"25","author":"AM Kroon","year":"1984","unstructured":"Kroon AM, Dontji BHJ, Holtrop M et al. The mitochondrial genetic system as target for chemotherapy: Tetracycline as cytostatics. Cancer Lett 1984; 25: 33\u201340.","journal-title":"Cancer Lett"},{"key":"278826_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0145-2126(85)90142-0","volume":"9","author":"C Van den Bogert","year":"1985","unstructured":"Van den Bogert C, Dontje B, Kroon A. The antitumor effect of doxycycline on a T-cell leukemia in the rat. Leukemia Res 1985; 9: 617\u2013623.","journal-title":"Leukemia Res"},{"key":"278826_CR3","first-page":"3283","volume":"46","author":"C Van den Bogert","year":"1986","unstructured":"Van den Bogert C, Dontje BHJ, Holtrop M et al. Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 1986; 46: 3283\u20133289.","journal-title":"Cancer Res"},{"key":"278826_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3835(94)90141-4","volume":"82","author":"BA Teicher","year":"1994","unstructured":"Teicher BA, Holden SA, Liu CJ et al. Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo. Cancer Lett 1994; 82: 17\u201325.","journal-title":"Cancer Lett"},{"key":"278826_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00689966","volume":"30","author":"EA Stomayor","year":"1992","unstructured":"Stomayor EA, Teicher BA, Schwartz GN et al. Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 1992; 30: 377\u2013384.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"A","key":"278826_CR6","first-page":"249","volume":"44","author":"RS Fife","year":"1996","unstructured":"Fife RS, Sledge GW Jr, Proctor C et al. Doxycycline inhibits matrix metalloproteinase activity and enhances apoptosis in human prostate cancer cells. J Invest Med 1996; 44(A): 249 (Abstr).","journal-title":"J Invest Med"},{"key":"278826_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0022-2143(97)90130-X","volume":"130","author":"RS Fife","year":"1997","unstructured":"Fife RS, Rougraff BT, Proctor C et al. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med 1997; 130: 530\u2013534.","journal-title":"J Lab Clin Med"},{"key":"278826_CR8","doi-asserted-by":"crossref","unstructured":"Fife RS, Sledge GW Jr. Effects of doxycycline on cancer cells in vitro and in vivo. Adv Dent Res 1998; 12: 94\u201396.","DOI":"10.1177\/08959374980120012801"},{"key":"278826_CR9","first-page":"407","volume":"125","author":"RS Fife","year":"1995","unstructured":"Fife RS, Sledge GW Jr. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med 1995; 125: 407\u2013411.","journal-title":"J Lab Clin Med"},{"key":"278826_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-3835(98)00003-2","volume":"127","author":"RS Fife","year":"1998","unstructured":"Fife RS, Sledge GW Jr, Roth BJ et al. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett 1998; 127: 37\u201341.","journal-title":"Cancer Lett"},{"key":"278826_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/08959374980120012901","volume":"12","author":"BL Lokeshwar","year":"1998","unstructured":"Lokeshwar BL, Houston-Clark HL, Selzer MG et al. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer. Adv Dent Res 1998; 12: 97\u2013102.","journal-title":"Adv Dent Res"},{"key":"278826_CR12","first-page":"312","volume":"17","author":"WC Duivenvoorden","year":"1997","unstructured":"Duivenvoorden WC, Hirte HW, Singh G. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. Invasion Metastasis 1997; 17: 312\u2013322.","journal-title":"Invasion Metastasis"},{"key":"278826_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","volume":"12","author":"LM Golub","year":"1998","unstructured":"Golub LM, Lee HM, Ryan ME et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998; 12: 12\u201326.","journal-title":"Adv Dent Res"},{"key":"278826_CR14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0022-5347(17)35268-0","volume":"151","author":"N Masumori","year":"1994","unstructured":"Masumori N, Tsukamoto T, Miyao N et al. Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma. J Urol 1994; 151: 1400\u20131404.","journal-title":"J Urol"},{"key":"278826_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/08959374980120010201","volume":"12","author":"N Masumori","year":"1998","unstructured":"Masumori N, Miyao N, Takahashi A et al. Minocycline inhibits in vitro invasion and experimental pulmonary metastasis of mouse renal adenocarcinoma. Adv Dent Res 1998; 12: 111\u2013113.","journal-title":"Adv Dent Res"},{"key":"278826_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","volume":"878","author":"BL. Lokeshwar","year":"1999","unstructured":"Lokeshwar BL. MMP inhibition in prostate cancer. Ann N Y Acad Sci 1999; 878: 271\u2013289.","journal-title":"Ann N Y Acad Sci"},{"key":"278826_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1749-6632.1999.tb07760.x","volume":"878","author":"MG Selzer","year":"1999","unstructured":"Selzer MG, Zhu B, Block NL et al. CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer. Ann N Y Acad Sci 1999; 878: 678\u2013682.","journal-title":"Ann N Y Acad Sci"},{"key":"278826_CR18","first-page":"327","volume":"13","author":"Y Cakir","year":"1999","unstructured":"Cakir Y, Hahn KA. Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro. In Vivo 1999; 13: 327\u2013331.","journal-title":"In Vivo"},{"key":"278826_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1006588708131","volume":"16","author":"RE Seftor","year":"1998","unstructured":"Seftor RE, Seftor EA, De Larco JE et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis 1998; 16: 217\u2013225.","journal-title":"Clin Exp Metastasis"},{"key":"278826_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<577::AID-IJC21>3.0.CO;2-J","volume":"86","author":"A Lukkonen","year":"2000","unstructured":"Lukkonen A, Sorsa ST, Tervahartiala T et al. Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration. Int J Cancer 2000; 86: 577\u2013581.","journal-title":"Int J Cancer"},{"key":"278826_CR21","first-page":"672","volume":"51","author":"RJ Tamargo","year":"1991","unstructured":"Tamargo RJ, Bok RA, Brein H. Angiogenesis inhibition by minocycline. Cancer Res 1991; 51: 672\u2013676.","journal-title":"Cancer Res"},{"key":"278826_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0304-3835(00)00348-7","volume":"153","author":"RS Fife","year":"2000","unstructured":"Fife RS, Sledge GW Jr, Sissons S et al. Effects of tetracyclines on angiogenesis in vitro. Cancer Lett 2000; 153: 75\u201378.","journal-title":"Cancer Lett"},{"key":"278826_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","volume":"2","author":"LM Golub","year":"1991","unstructured":"Golub LM, Greenwald RA, Ramamurthy NS et al. Tetracyclines inhibit connenctive tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991; 2: 297\u2013322.","journal-title":"Crit Rev Oral Biol Med"},{"key":"278826_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-051X.1995.tb00120.x","volume":"22","author":"LM Golub","year":"1995","unstructured":"Golub LM, Sorsa T, Lee HM. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995; 22: 100\u2013109.","journal-title":"J Clin Periodontol"},{"key":"278826_CR25","first-page":"295","volume":"63","author":"MI Cockett","year":"1998","unstructured":"Cockett MI, Murphy G, Birch ML et al. Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 1998; 63: 295\u2013313.","journal-title":"Biochem Soc Symp"},{"key":"278826_CR26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","volume":"18","author":"AR Nelson","year":"2000","unstructured":"Nelson AR, Fingleton B, Rothenberg ML et al. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135\u20131149.","journal-title":"J Clin Oncol"},{"key":"278826_CR27","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1038\/sj.onc.1202116","volume":"16","author":"S Fan","year":"1998","unstructured":"Fan S, Wang JA, Yuan RQ et al. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene 1998; 16: 3069\u20133082.","journal-title":"Oncogene"},{"key":"278826_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s001090000088","volume":"78","author":"Q Meng","year":"2000","unstructured":"Meng Q, Qi M, Chen DZ et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: Associated with up-regulation of BRCA1 and E-cadherin\/catenin complexes. J Mol Med 2000; 78: 155\u2013165.","journal-title":"J Mol Med"},{"key":"278826_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0168-9525(93)90250-L","volume":"9","author":"R. Kemler","year":"1993","unstructured":"Kemler R. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993; 9: 317\u2013321.","journal-title":"Trends Genet"},{"key":"278826_CR30","first-page":"123","volume":"213","author":"ME Bracke","year":"1996","unstructured":"Bracke ME, Van Roy FM, Mareel MM. The E-cadherin\/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 1996; 213: 123\u2013161.","journal-title":"Curr Top Microbiol Immunol"},{"key":"278826_CR31","first-page":"561","volume":"17","author":"W Zschiesche","year":"1997","unstructured":"Zschiesche W, Schonborn I, Behrens J et al. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 1997; 17: 561\u2013567.","journal-title":"Anticancer Res"},{"key":"278826_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y","volume":"185","author":"IK Bukholm","year":"1998","unstructured":"Bukholm IK, Nesland JM, Karesen R et al. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998; 185: 262\u2013266.","journal-title":"J Pathol"},{"key":"278826_CR33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/ajcp\/105.4.394","volume":"105","author":"SM Siitonen","year":"1996","unstructured":"Siitonen SM, Kononen JT, Helin HJ et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996; 105: 394\u2013402.","journal-title":"Am J Clin Pathol"},{"key":"278826_CR34","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","volume":"14","author":"G Berx","year":"1995","unstructured":"Berx G, Cleton-Jansen AM, Nollet F et al. E-cadherin is a tumour\/ invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107\u20136115.","journal-title":"EMBO J"},{"key":"278826_CR35","first-page":"1919","volume":"13","author":"G Berx","year":"1996","unstructured":"Berx G, Cleton-Jansen AM, Strumane K et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919\u20131925.","journal-title":"Oncogene"},{"key":"278826_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","volume":"183","author":"WJ De Leeuw","year":"1997","unstructured":"De Leeuw WJ, Berx G, Vos CB et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404\u2013411.","journal-title":"J Pathol"},{"key":"278826_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF01092751","volume":"430","author":"NC Hunt","year":"1997","unstructured":"Hunt NC, Douglas-Jones AG, Jasani B et al. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997; 430: 285\u2013289.","journal-title":"Virchows Arch"},{"key":"278826_CR38","first-page":"1972","volume":"58","author":"S Hiraguri","year":"1998","unstructured":"Hiraguri S, Godfrey T, Nakamura H et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 1998; 58: 1972\u20131977.","journal-title":"Cancer Res"},{"key":"278826_CR39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcp\/109.4.431","volume":"109","author":"C Charpin","year":"1998","unstructured":"Charpin C, Garcia S, Bonnier P et al. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am J Clin Pathol 1998; 109: 431\u2013838.","journal-title":"Am J Clin Pathol"},{"key":"278826_CR40","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1038\/sj.onc.1202790","volume":"18","author":"G Handschuh","year":"1999","unstructured":"Handschuh G, Candidus S, Luber B et al. Tumour-associated Ecadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18: 4301\u20134312.","journal-title":"Oncogene"},{"key":"278826_CR41","first-page":"4063","volume":"56","author":"G Mbalaviele","year":"1996","unstructured":"Mbalaviele G, Dunstan CR, Sasaki A et al. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996; 56: 4063\u20134070.","journal-title":"Cancer Res"},{"key":"278826_CR42","first-page":"4607","volume":"54","author":"ME Bracke","year":"1994","unstructured":"Bracke ME, Charlier C, Bruyneel EA et al. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7\/6 cells and suppresses their invasive phenotype. Cancer Res 1994; 54: 4607\u20134609.","journal-title":"Cancer Res"},{"key":"278826_CR43","first-page":"4383","volume":"58","author":"S Cos","year":"1998","unstructured":"Cos S, Fernandez R, Guezmes A et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58: 4383\u20134390.","journal-title":"Cancer Res"},{"key":"278826_CR44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66\u201371.","journal-title":"Science"},{"key":"278826_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng0495-444","volume":"9","author":"ME Thompson","year":"1995","unstructured":"Thompson ME, Jensen RA, Obermiller PS et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995; 9: 444\u2013450.","journal-title":"Nat Genet"},{"key":"278826_CR46","first-page":"849","volume":"13","author":"PG Rio","year":"1998","unstructured":"Rio PG, Pernin D, Bay JO et al. Loss of heterozygosity of BRCA1, BRCA2 and ATMgenes in sporadic invasive ductal breast carcinoma. Int J Oncol 1998;13: 849\u2013853.","journal-title":"Int J Oncol"},{"key":"278826_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3","volume":"80","author":"PG Rio","year":"1999","unstructured":"Rio PG, Maurizis JC, Peffault de Latour M et al. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer 1999; 80: 823\u2013826.","journal-title":"Int J Cancer"},{"key":"278826_CR48","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W","volume":"79","author":"J Taylor","year":"1998","unstructured":"Taylor J, Lymboura M, Pace PE et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer 1998; 79: 334\u2013342.","journal-title":"Int J Cancer"},{"key":"278826_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1006082117266","volume":"53","author":"JM Silva","year":"1999","unstructured":"Silva JM, Gonzalez R, Provencio M et al. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat 1999; 53: 9\u201317.","journal-title":"Breast Cancer Res Treat"},{"key":"278826_CR50","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<258::AID-IJC10>3.0.CO;2-H","volume":"84","author":"LT Seery","year":"1999","unstructured":"Seery LT, Knowlden JM, Gee JM et al. BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 1999; 84: 258\u2013262.","journal-title":"Int J Cancer"},{"key":"278826_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/6029","volume":"21","author":"CA Wilson","year":"1999","unstructured":"Wilson CA, Ramos L, Villasenor MR et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999; 21: 236\u2013240.","journal-title":"Nat Genet"},{"key":"278826_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/8743","volume":"22","author":"X Xu","year":"1999","unstructured":"Xu X, Wagner KU, Larson D et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999; 22: 37\u201343.","journal-title":"Nat Genet"},{"key":"278826_CR53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s001090050053","volume":"74","author":"M Jeffers","year":"1996","unstructured":"Jeffers M, Rong S, Woude GF. Hepatocyte growth factor\/scatter factor-Met signaling in tumorigenicity and invasion\/metastasis. J Mol Med 1996; 74: 505\u2013513.","journal-title":"J Mol Med"},{"key":"278826_CR54","first-page":"119","volume":"212","author":"GF Vande Woude","year":"1997","unstructured":"Vande Woude GF, Jeffers M, Cortner J etval. Met-HGF\/SF: tumorigenesis, invasion and metastasis. Ciba Found Symp 1997; 212: 119\u2013130","journal-title":"Ciba Found Symp"},{"key":"278826_CR55","first-page":"145","volume-title":"Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Application","author":"E Rosen","year":"1999","unstructured":"Rosen E, Lamszus K, Laterra J et al. Scatter factor as a tumor angiogenesis factor. In Rubanyi GM (ed): Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Application. New York: Marcel Dekker 1999; 145\u201356."},{"key":"278826_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<274::AID-IJC19>3.0.CO;2-2","volume":"82","author":"R Hamasuna","year":"1999","unstructured":"Hamasuna R, Kataoka H, Moriyama T et al. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor\/scatter factor (HGF\/SF) in human glioma cells: HGF\/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 1999; 82: 274\u2013281.","journal-title":"Int J Cancer"},{"key":"278826_CR57","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0022-5347(01)61834-2","volume":"161","author":"S Horie","year":"1999","unstructured":"Horie S, Aruga S, Kawamata H et al. Biological role of HGF\/MET pathway in renal cell carcinoma. J Urol 1999;161: 990\u2013997.","journal-title":"J Urol"},{"key":"278826_CR58","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0168-9525(93)90250-L","volume":"9","author":"R. Kemler","year":"1993","unstructured":"Kemler R. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993; 9: 317\u2013321.","journal-title":"Trends Genet"},{"key":"278826_CR59","unstructured":"Bowers DC, Fan S, Williams JA et al. Hepatocyte growth factor activates the AKT pathway and protects against cytotoxic death in glioma cells. Cancer Res 2000; in press."},{"key":"278826_CR60","first-page":"819","volume":"64","author":"BR Rifkin","year":"1993","unstructured":"Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemicallly modified analogs. Am Acad Periodontol 1993; 64: 819\u2013827.","journal-title":"Am Acad Periodontol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006732424102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006732424102\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006732424102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T21:58:45Z","timestamp":1752357525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006732424102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["278826"],"URL":"https:\/\/doi.org\/10.1023\/a:1006732424102","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}